APOA1 and gastric cancer: The APOE ε2 allele affects different lipid metabolism markers across various tumors, ApoA1 levels are significantly increased in patients with early-stage gastric cancer, whereas they remain relatively stable in those with advanced-stage gastric cancer (38, 39).